Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.93 USD | +4.94% | +3.21% | +71.61% |
05-02 | Baird Starts Spyre Therapeutics With Outperform Rating, $50 Price Target | MT |
04-19 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.61% | 1.42B | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Stifel Adjusts Spyre Therapeutics' Price Target to $54 From $36, Maintains Buy Rating